MEDI7352 + Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Painful Osteoarthritis of the Knee
Conditions
Painful Osteoarthritis of the Knee
Trial Timeline
Apr 20, 2021 → Dec 2, 2021
NCT ID
NCT04770428About MEDI7352 + Placebo
MEDI7352 + Placebo is a phase 1 stage product being developed by AstraZeneca for Painful Osteoarthritis of the Knee. The current trial status is completed. This product is registered under clinical trial identifier NCT04770428. Target conditions include Painful Osteoarthritis of the Knee.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04770428 | Phase 1 | Completed |
Competing Products
20 competing products in Painful Osteoarthritis of the Knee